Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 1, 2009, Pages 38-48

  Prasad, Kailash ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Antioxidant reserve; Flax lignan complex; Hypercholesterolemia; Malondialdehyde; Oxygen radicals; Slowing of progression of atherosclerosis; White blood cell chemiluminescence

Indexed keywords

ANTIOXIDANT; FLAX LIGNAN COMPLEX; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; DISEASE COURSE; HYPERLIPIDEMIA; INTIMA; LEUKOCYTE; LIPID ANALYSIS; LIPID BLOOD LEVEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; AORTA; ATHEROSCLEROSIS; BODY WEIGHT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FLAX; HYPERCHOLESTEROLEMIA; LEUKOCYTES; LIGNANS; LIPIDS; MALONDIALDEHYDE; OXIDATIVE STRESS; RABBITS; TIME FACTORS;

EID: 61449102645     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248408330541     Document Type: Article

References (46)

1. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation. 1999; 99: 1355-1362.
2. Prasad K. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis. 2005; 179: 269-275.
3. Prasad K., Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J. 1993; 125: 958-973.
4. Prasad K., Lee P. Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. Atherosclerosis. 2007; 192: 313-322.
5. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Circulation. 1992; 85: 2337-2344.
6. Lee P., Prasad K. Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by cyclooxygenase inhibitors. Int J Angiol. 2003; 12: 13-23.
7. Prasad K., Kalra J., Lee P. Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: effects of probucol. Int J Angiol. 1994; 3: 10-12.
8. Westcott ND, Paton D. A complex containing lignan, phenolic and aliphatic substances from flax and process for preparing. U.S. Patent 6,264,853 (July 24, 2001 ).
9. Prasad K. Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Mol Cell Biochem. 1997; 168: 117-123.
10. Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol. 2000; 9: 220-225.
11. Foti M., Piatelli M., Baratta MT Flavonoids, coumarins, and cinnamic acids as antioxidants in a micellar system: structure-activity relationship. J Agric Food Chem. 1996 ; 44: 497-501.
12. Daugherty A., Zweifel BS, Schonfeld G. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidemic rabbits. Br J Pharmacol. 1991; 103: 1013-1018.
13. Kita T., Nagano Y., Yokode M., et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA. 1987; 84: 5928-5931.
14. Stein Y., Stein O. Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions ? Arterioscler Thromb Vasc Biol. 2001; 21: 183-188.
15. van de Poll SW, Delsing DJ, Wouter Jukema J., et al. Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice. J Mol Coll Cardiol. 2003; 35: 109-118.
16. Kapoor R., Prasad K. Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion: effect of SOD and catalase. Circ Shock. 1994; 43: 79-94.
17. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-358.
18. Holman RL, McGill HC Jr, Strong JP, Geer JC Techniques for studying atherosclerotic lesions. Lab Invest. 1958; 7: 42-47.
19. Gornall AG, Bardawill CJ, David MM Determination of serum proteins by means of biuret reaction. J Biol Chem. 1949; 177: 751-766.
20. Zhu BQ, Sievers RE, Sun YP, Iconberg WM, Parmley WW Effect of lovastatin on suppression and regression of atherosclerosis in lipid-fed rabbits. J Cardiovasc Pharmacol. 1992; 19: 246-255.
21. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Moorehead TJ, Parmley WW Effects of etidronate and lovastatin on the regression of atherosclerosis in cholesterol-fed rabbits. Cardiology. 1994; 85: 370-377.
22. Kano H., Hayashi T., Sumi D., et al. A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA. Biochem Biophys Res Commun. 1999; 259: 414-419.
23. Dowell FJ, Hamilton CA, Lindop GB, Reid JL Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits: effects of simvastatin treatment. Arterioscler Thromb Vasc Biol. 1995; 15: 1152-1160.
24. Fukuo Y., Nagashima M., Saitoh A., et al. Effects of simvastatin on serum lipids and atherosclerosis in WHHL rabbits. Clin Ther. 1991; 13: 417-424.
25. Heart Protection Study Collaborative group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360: 7-22.
26. Prasad K. Pathophysiology of atherosclerosis. In: Chang JB, Olsen ER, Prasad K, Sumpio BE, eds. Textbook of Angiology. New York, NY: Springer; 2000: 85-105.
27. Prasad K., Lee P., Mantha SV, Kalra J., Prasad M., Gupta JB Detection of ischemia-reperfusion cardiac injury by cardiac chemiluminescence. Mol Cell Biochem. 1992; 115: 49-58.
28. Mantha SV, Prasad M., Kalra J., Prasad K. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. Atherosclerosis. 1993; 101: 135-144.
29. McCafferty AC, Cree IA, McMurdo ME The influence of age and sex on phagocyte chemiluminescence. J Biolumin Chemilumin. 1995; 10: 41-48.
30. Coelho Horta B., Steinberg Perilo C., Caldeira Costa D., Nogueria-Machado JA, Martins Chaves M. Aging: functional metabolic balance among cAMP, cGMP and reactive oxygen intermediate generation by human granulocytes. Gerontology. 2005; 51: 363-368.
31. Warren JS, Ward PA Oxidative injury to the vascular endothelium. Am J Med Sci. 1986; 292: 97-103.
32. Martin A., Foxall T., Blumberg JB, Meydani M. Vitamin E inhibits low density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler Thromb Vasc Biol. 1997; 17: 429-436.
33. Chiu JJ, Wung BS, Shyy JY, Hsieh HJ, Wang DL Reactive oxygen species are involved in shear stress-induced intracellular adhesion molecule-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol. 1997; 17: 3570-3577.
34. Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 1990; 87: 5134-5138.
35. Rajagopalan S., Meng XP, Ramasamy S., Harrison DG, Galis ZS Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996; 98: 2572-2579.
36. Böger RH, Bode-Böger SM, Mügge A., et al. Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis. 1995; 117: 273-284.
37. Böger RH, Bode-Böger SM, Brandes RP, et al. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation. 1997; 96: 1282-1290.
38. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992; 339: 572-575.
39. Cooke JP, Singer AH, Tsao P., Zera P., Rowan RA, Billingham ME Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992; 90: 1168-1172.
40. Habib JB, Bossaller C., Wells S., Williams C., Morrisett JD, Henry PD Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbits by treatment with calcium blocker PN 200110. Circ Res. 1986; 58: 305-309.
41. Riezebos J., Vleeming W., Beems RB, et al. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits, II: effect on regression of atherosclerosis and restoration of endothelial function. J Cardiovasc Pharmacol. 1994; 23: 424-431.
42. Salonen R., Nyyssönen K., Porkkala E., et al. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL-lowering on atherosclerotic progression in carotid and femoral arteries. Circulation. 1995; 92: 1758-1764.
43. Burton JR, Teo KK, Buller CE, et al, and the SCAT investigators. Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT). Can J Cardiol. 2003; 19: 487-491.
44. Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation. 2004; 110: 3512-3517.
45. Levy AP, Friedenberg P., Lotan R., et al. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women. Diabetes Care. 2004; 27: 925-930.
46. Prasad K. Antihypertensive activity of secoisolariciresinol diglucoside isolated from flaxseed: role of guanylate cyclase. Int J Angiol. 2004; 13: 7-14.